0
Scientific Exhibits   |    
Hip Prosthesis of Antibiotic-Loaded Acrylic Cement for the Treatment of Infections Following Total Hip Arthroplasty
Steven J. Wentworth, BS; Bassam A. Masri, MD; Clive P. Duncan, MD; Carleton B. Southworth, BA, MS
View Disclosures and Other Information
Corresponding author:
Bassam A. Masri, MD
Department of Orthopaedics, Vancouver Hospital and Health Sciences Center, University of British Columbia, Vancouver, British Columbia, Canada, V5Z4E1. E-mail address for B. Masri: masri@interchange.ubc.ca


The authors did not receive grants or outside funding in support of their research or preparation of this manuscript. One or more of the authors received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity (DePuy). No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

J Bone Joint Surg Am, 2002 Nov 01;84(suppl 2):S123-S128
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case

Extract

Infection continues to be one of the most feared complications of total hip arthroplasty. Despite many advances over the past three decades, this infrequent complication continues to undermine an otherwise highly predictable and successful procedure. The prosthesis of antibiotic-loaded acrylic cement (PROSTALAC; DePuy, Warsaw, Indiana) is a temporary hip-replacement articulated spacer intended for patients who need a two-stage exchange arthroplasty for the treatment of a confirmed or suspected infection at the site of a total hip replacement. This device has received approval from the United States Food and Drug Administration as a humanitarian use device. (This humanitarian device has been authorized by federal law as a short-term total hip replacement [THR] in patients who need a two-stage procedure to treat a confirmed infection of their THR and where vancomycin and tobramycin are the most appropriate antibiotics for treatment of the infection based on the susceptibility pattern of the infecting microorganism[s]. The effectiveness of this device for this use has not been determined.) The early experience with 135 patients who were treated with the PROSTALAC implant is reported. Initial experience has also been reported in previous publications 1-2 .
Figures in this Article

    First Page Preview

    View Large
    />
    First page PDF preview
    Sign In to Your Personal ProfileSign In To Access Full Content
    Not a Subscriber?
    Get online access for 30 days for $35
    New to JBJS?
    Sign up for a full subscription to both the print and online editions
    Register for a FREE limited account to get full access to all CME activities, to comment on public articles, or to sign up for alerts.
    Register for a FREE limited account to get full access to all CME activities
    Have a subscription to the print edition?
    Current subscribers to The Journal of Bone & Joint Surgery in either the print or quarterly DVD formats receive free online access to JBJS.org.
    Forgot your password?
    Enter your username and email address. We'll send you a reminder to the email address on record.

     
    Forgot your username or need assistance? Please contact customer service at subs@jbjs.org. If your access is provided
    by your institution, please contact you librarian or administrator for username and password information. Institutional
    administrators, to reset your institution's master username or password, please contact subs@jbjs.org

    References

    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe





    Related Content
    The Journal of Bone & Joint Surgery
    JBJS Case Connector
    Topic Collections
    Related Audio and Videos
    Guidelines
    Feverish illness in children: assessment and initial management in children younger than 5 years. -National Collaborating Centre for Women's and Children's Health | 8/28/2009
    Blepharitis. -American Academy of Ophthalmology | 6/5/2009
    Results provided by:
    PubMed
    Clinical Trials
    Readers of This Also Read...
    JBJS Jobs
    03/27/2014
    MA - Boston Medical Center and Boston University School of Medicine
    10/12/2011
    NY - Modern Chiropractic Care, P.C.
    03/05/2014
    OK - The University of Oklahoma
    12/04/2013
    NY - Icahn School of Medicine at Mount Sinai